Skip to content
10-K

Annual Report

Myovant Sciences Ltd.

0001679082-22-000071

← back to feed
Filed
May 11, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2022 · May 6, 2022 95.33M sh
Shares Diluted FY 2022 · Mar 31, 2022 92.97M sh
Shares Diluted FY 2022 · Mar 31, 2021 90.04M sh
Shares Diluted FY 2022 · Mar 31, 2020 85.84M sh
Capex FY 2022 · Mar 31, 2022 $974K
Capex FY 2022 · Mar 31, 2021 $1.77M
Capex FY 2022 · Mar 31, 2020 $1.1M
Operating Cash Flow FY 2022 · Mar 31, 2022 −$268.56M
Operating Cash Flow FY 2022 · Mar 31, 2021 $370.63M
Operating Cash Flow FY 2022 · Mar 31, 2020 −$221.17M
Cash And Equivalents FY 2022 · Mar 31, 2022 $406.7M
Cash And Equivalents FY 2022 · Mar 31, 2021 $674.49M
Cash And Equivalents FY 2022 · Mar 31, 2020 $76.64M
Stockholders Equity FY 2022 · Mar 31, 2022 −$473.48M
Stockholders Equity FY 2022 · Mar 31, 2021 −$353.97M
Stockholders Equity FY 2022 · Mar 31, 2020 −$108.28M
Stockholders Equity FY 2022 · Mar 31, 2019 $4.33M
Current Liabilities FY 2022 · Mar 31, 2022 $250.33M
Current Liabilities FY 2022 · Mar 31, 2021 $281.34M
Total Liabilities FY 2022 · Mar 31, 2022 $993.49M
Total Liabilities FY 2022 · Mar 31, 2021 $1.08B
Current Assets FY 2022 · Mar 31, 2022 $488.15M
Current Assets FY 2022 · Mar 31, 2021 $704.65M
Total Assets FY 2022 · Mar 31, 2022 $520.01M
Total Assets FY 2022 · Mar 31, 2021 $725.03M
Eps Diluted FY 2022 · Mar 31, 2022 −$2.22
Eps Diluted FY 2022 · Mar 31, 2021 −$2.83
Eps Diluted FY 2022 · Mar 31, 2020 −$3.37
Eps Basic FY 2022 · Mar 31, 2022 −$2.22
Eps Basic FY 2022 · Mar 31, 2021 −$2.83
Eps Basic FY 2022 · Mar 31, 2020 −$3.37
Sga Expense FY 2022 · Mar 31, 2022 $259.36M
Sga Expense FY 2022 · Mar 31, 2021 $181.42M
Sga Expense FY 2022 · Mar 31, 2020 $82.33M
Rd Expense FY 2022 · Mar 31, 2022 $107.4M
Rd Expense FY 2022 · Mar 31, 2021 $136.71M
Rd Expense FY 2022 · Mar 31, 2020 $192.56M
Net Income FY 2022 · Mar 31, 2022 −$205.98M
Net Income FY 2022 · Mar 31, 2021 −$255.13M
Net Income FY 2022 · Mar 31, 2020 −$288.99M
Operating Income FY 2022 · Mar 31, 2022 −$187.35M
Operating Income FY 2022 · Mar 31, 2021 −$260.78M
Operating Income FY 2022 · Mar 31, 2020 −$274.89M